# Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

> **NCT00003084** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 75 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Doxorubicin Hydrochloride
- **DRUG:** Estramustine phosphate sodium
- **DRUG:** Etoposide
- **DRUG:** Ketoconazole
- **DRUG:** Paclitaxel
- **DRUG:** Vinblastine

## Key facts

- **NCT ID:** NCT00003084
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** 2002-11
- **Final completion:** 2002-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003084, "Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*